He C J, Peraldi M N, Adida C, Rebibou J M, Meulders Q, Sraer J D, Rondeau E
INSERM U 64, Hôpital Tenon, Paris, France.
J Cell Physiol. 1992 Mar;150(3):475-83. doi: 10.1002/jcp.1041500307.
We have previously shown that alpha-thrombin exerted a mitogenic effect on human glomerular epithelial cells and stimulated the synthesis of urokinase-type (u-PA) and tissue-type plasminogen activator (t-PA) and of their inhibitor, plasminogen activator inhibitor 1 (PAI-1). In the present study, we investigate the signal transduction mechanisms of thrombin in these cultured cells. Thrombin induced an increase in intracellular free calcium concentrations ([Ca2+]i) in a dose-dependent manner, a plateau being reached at 1 U/ml thrombin. A 60% inhibition of this effect was produced by 300 nM nicardipine, a dihydroperidine agent, or by 4 mM EGTA, indicating that increase in [Ca2+]i was due in part to extracellular Ca2+ entry through L-type voltage-sensitive calcium channels. Thrombin also induced an increase in inositol trisphosphate (IP3), suggesting that phospholipase C activation and phosphatidylinositides breakdown were stimulated. Interestingly thrombin-stimulated cell proliferation measured by 3H thymidine incorporation was inhibited by 300 nM nicardipine, and restored by addition of 10(-8) M ionomycin, indicating that calcium entry was critical for the mitogenic signal of thrombin. Conversely, nicardipine did not modify thrombin-stimulated synthesis of u-PA, t-PA, and PAI-1. Both thrombin-stimulated cell proliferation and protein synthesis required protein kinase C activation since these effects were blocked by 10 microM H7, an inhibitor of protein kinases, and by desensitization of protein kinase C by phorbol ester pretreatment of the cells. Interestingly, DFP-inactivated thrombin which binds the thrombin receptor and gamma-thrombin, which has some enzymatic activity but does not bind to thrombin receptor, had no effect when used alone. Simultaneous addition of these two thrombin derivatives had no effect on [Ca2+]i, and 3H thymidine incorporation but stimulated u-PA, t-PA, and PAI-1 synthesis although to a lesser extent than alpha-thrombin. This effect also required protein kinase C activation to occur, presumably by a pathway distinct from phosphoinositoside turnover since it was not associated with IP3 generation. In conclusion, multiple signalling pathways can be activated by alpha-thrombin in glomerular epithelial cells: 1) Ca2+ influx through a dihydroperidine-sensitive calcium channel, which seems critical for mitogenesis; 2) protein kinase C activation by phosphoinositide breakdown, which stimulates both mitogenesis and synthesis of u-PA, t-PA, and PAI-1; 3) protein kinase C activation by other phospholipid breakdown can stimulate u-PA, t-PA, and PAI-1 synthesis but not mitogenesis.
我们之前已经表明,α-凝血酶对人肾小球上皮细胞具有促有丝分裂作用,并刺激尿激酶型(u-PA)、组织型纤溶酶原激活剂(t-PA)及其抑制剂纤溶酶原激活剂抑制剂1(PAI-1)的合成。在本研究中,我们研究了凝血酶在这些培养细胞中的信号转导机制。凝血酶以剂量依赖性方式诱导细胞内游离钙浓度([Ca2+]i)升高,在1 U/ml凝血酶时达到平台期。300 nM尼卡地平(一种二氢吡啶类药物)或4 mM乙二醇双四乙酸(EGTA)可对该效应产生60%的抑制,表明[Ca2+]i的升高部分归因于细胞外Ca2+通过L型电压敏感性钙通道的内流。凝血酶还诱导肌醇三磷酸(IP3)增加,提示磷脂酶C被激活且磷脂酰肌醇分解受到刺激。有趣的是,通过3H胸苷掺入法测定的凝血酶刺激的细胞增殖受到300 nM尼卡地平的抑制,并通过添加10(-8) M离子霉素得以恢复,表明钙内流对于凝血酶的促有丝分裂信号至关重要。相反,尼卡地平并未改变凝血酶刺激的u-PA、t-PA和PAI-1的合成。凝血酶刺激的细胞增殖和蛋白质合成均需要蛋白激酶C激活,因为这些效应被10 μM H7(一种蛋白激酶抑制剂)以及通过佛波酯预处理细胞使蛋白激酶C脱敏所阻断。有趣的是,与凝血酶受体结合的二异丙基氟磷酸(DFP)灭活的凝血酶以及具有一些酶活性但不与凝血酶受体结合的γ-凝血酶单独使用时均无作用。同时添加这两种凝血酶衍生物对[Ca2+]i和3H胸苷掺入无影响,但刺激了u-PA、t-PA和PAI-1的合成,尽管程度低于α-凝血酶。该效应也需要蛋白激酶C激活才能发生,推测是通过一条不同于磷酸肌醇周转的途径,因为它与IP3的产生无关。总之,α-凝血酶可在肾小球上皮细胞中激活多种信号通路:1)通过二氢吡啶敏感性钙通道的Ca2+内流,这似乎对有丝分裂至关重要;2)通过磷脂酰肌醇分解激活蛋白激酶C,这刺激有丝分裂以及u-PA、t-PA和PAI-1的合成;3)通过其他磷脂分解激活蛋白激酶C可刺激u-PA、t-PA和PAI-1的合成,但不刺激有丝分裂。